Evidence map›Paper›PMID 38359122›Full record

ArticleScience (New York, N.Y.)2024

ATR blocks telomerase from converting DNA breaks into telomeres.

Charles G Kinzig, George Zakusilo, Kaori K Takai, Logan R Myler, Titia de Lange

Open access · greenAbstract read
In one paragraph

Article in Science (New York, N.Y.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. How telomere attrition protects against cancer.Nature reviews. Genetics · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Evolution of Prime Editing: Enhancing Efficiency and Expanding Capacity.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  8. Article
  9. Article
  10. Science advances · 2025
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Telomerase misbehaves after a breakup.Science (New York, N.Y.) · 2024
    Article
  19. Telomere maintenance and the DNA damage response: a paradoxical alliance.Frontiers in cell and developmental biology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Charles G KinzigLaboratory for Cell Biology and Genetics, The Rockefeller University, New York, NY 10065, USA.ORCID 0000-0002-4592-7411
George ZakusiloLaboratory for Cell Biology and Genetics, The Rockefeller University, New York, NY 10065, USA.
Kaori K TakaiLaboratory for Cell Biology and Genetics, The Rockefeller University, New York, NY 10065, USA.
Logan R MylerLaboratory for Cell Biology and Genetics, The Rockefeller University, New York, NY 10065, USA.ORCID 0000-0003-0673-7049
Titia de LangeLaboratory for Cell Biology and Genetics, The Rockefeller University, New York, NY 10065, USA.ORCID 0000-0002-9267-367X
Rockefeller University · USCornell University · US

Funding

Weill Cornell/Rockefeller/Sloan-Kettering MST ProgramT32GM007739 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI HSU, KATHARINE C · 1985 to 2023
$51.1M
MECHANISMS OF TELOMERE INDUCED SENESCENCER01AG016642 · NIA · ROCKEFELLER UNIVERSITY · PI Titia de Lange · 1999 to 2026
$11.9M
Genome instability in cancer: telomeres and DNA repairR35CA210036 · NCI · ROCKEFELLER UNIVERSITY · PI Titia de Lange · 2016 to 2026
$10.8M
Telomerase-Mediated Healing of Double-Strand Breaks in Human CellsF30CA257419 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI KINZIG, CHARLES GUNNAR · 2021 to 2024
$189k
NCI NIH HHS F30 CA257419NCI NIH HHS R35 CA210036NIGMS NIH HHS T32 GM007739
6 · The paper itself

Abstract

Telomerase, the enzyme that maintains telomeres at natural chromosome ends, should be repressed at double-strand breaks (DSBs), where neotelomere formation can cause terminal truncations. We developed an assay to detect neotelomere formation at Cas9- or I-SceI-induced DSBs in human cells. Telomerase added telomeric repeats to DSBs, leading to interstitial telomeric repeat insertions or the formation of functional neotelomeres accompanied by terminal deletions. The threat that telomerase poses to genome integrity was minimized by ataxia telangiectasia and Rad3-related (ATR) kinase signaling, which inhibited telomerase at resected DSBs. In addition to acting at resected DSBs, telomerase used the extruded strand in the Cas9 enzyme-product complex as a primer for neotelomere formation. We propose that although neotelomere formation is detrimental in normal human cells, it may allow cancer cells to escape from breakage-fusion-bridge cycles.

Indexed as

Ataxia Telangiectasia Mutated ProteinsDNA Breaks, Double-StrandedTelomeraseTelomereCRISPR-Associated Protein 9Genetic TechniquesHeLa CellsHumansAtaxia Telangiectasia Mutated ProteinsATR protein, humanCas9 protein, Francisella novicidaCRISPR-Associated Protein 9Telomerase

Identifiers

PMID38359122
PMCPMC11267623
OpenAlexW4391839268

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.